$NVO (makes ozempic) just killed TWO Phase 3 trials

Halted two additional trials of its experimental cardiovascular drug ziltivekimab, further denting ‌the Danish drugmaker's efforts to diversify beyond its blockbuster obesity and diabetes franchise Novo scraps two more heart drug trials, further dimming growth beyond obesity   submitted by   /u/dhonshuk [link]   [comments]

重要性：RSS 导入条目，等待编辑或代理补充市场影响解读。